BMO Capital Maintains Novartis AG(NVS.US) With Hold Rating, Maintains Target Price $118
Erste Group Maintains Novartis AG(NVS.US) With Buy Rating
Novartis Cut to Neutral From Buy by Goldman Sachs
Novartis Analyst Ratings
Goldman Sachs Downgrades Novartis AG(NVS.US) to Hold Rating, Raises Target Price to $121
Novartis Target Cut to $105 From $110 by Jefferies
Jefferies Downgrades Novartis AG(NVS.US) to Hold Rating, Raises Target Price to $123.5
Novartis AG (NOVN) Receives a Buy From Kepler Capital
Berenberg Raises Price Target on Novartis to CHF86 From CHF77, Maintains Hold Rating
Novartis AG (NOVN) Gets a Hold From Berenberg Bank
Analysts' Opinions Are Mixed on These Healthcare Stocks: Novartis AG (Six Swiss: CH:NOVN), Biogen (BIIB) and Sartorius (GB:0NIR)
Novartis AG (NOVN) Gets a Buy From Kepler Capital
Deutsche Numis Downgrades Novartis AG (NOVN) to a Hold
Barclays Keeps Their Sell Rating on Novartis AG (NOVN)
Buy Rating for Novartis AG on Robust Earnings and Promising Growth Outlook
Jefferies Remains a Buy on Novartis AG (NOVN)
UBS Sticks to Their Buy Rating for Novartis AG (NOVN)
Novartis AG (NOVN) Gets a Hold From Citi
Novartis Analyst Ratings
Berenberg Raises Price Target on Novartis to CHF77 From CHF74, Maintains Hold Rating